Universal Corporation Ltd (UCL), with support from MMV and Unitaid, becomes the first African manufacturer to gain WHO prequalification of sulfadoxine-pyrimethamine
First African-manufactured medicine to prevent malaria in pregnant women and infants quality-approved by WHO
Diverse compound collection harnesses open innovation to advance global health priorities
MMV and IVCC make 240 compounds available to stimulate research into new drugs and insecticides
ARCTIC will explore the operational feasibility of quantitative G6PD testing prior to treatment with tafenoquine or primaquine.